100 related articles for article (PubMed ID: 28670978)
1. A novel BLK-induced tumor model.
Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
[TBL] [Abstract][Full Text] [Related]
3. B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
Petersen DL; Krejsgaard T; Berthelsen J; Fredholm S; Willerslev-Olsen A; Sibbesen NA; Bonefeld CM; Andersen MH; Francavilla C; Olsen JV; Hu T; Zhang M; Wasik MA; Geisler C; Woetmann A; Odum N
Leukemia; 2014 Oct; 28(10):2109-12. PubMed ID: 24919804
[No Abstract] [Full Text] [Related]
4. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
[TBL] [Abstract][Full Text] [Related]
6. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
Dymecki SM; Niederhuber JE; Desiderio SV
Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells.
Simpfendorfer KR; Armstead BE; Shih A; Li W; Curran M; Manjarrez-Orduño N; Lee AT; Diamond B; Gregersen PK
Arthritis Rheumatol; 2015 Nov; 67(11):2866-76. PubMed ID: 26246128
[TBL] [Abstract][Full Text] [Related]
8. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.
Texido G; Su IH; Mecklenbräuker I; Saijo K; Malek SN; Desiderio S; Rajewsky K; Tarakhovsky A
Mol Cell Biol; 2000 Feb; 20(4):1227-33. PubMed ID: 10648608
[TBL] [Abstract][Full Text] [Related]
9. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.
Yao XR; Scott DW
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139
[TBL] [Abstract][Full Text] [Related]
11. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK).
Fu T; Zuo Y; Zhong Z; Chen X; Pan Z
Eur J Med Chem; 2022 Feb; 229():114051. PubMed ID: 34952433
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase.
Fu T; Zuo Y; Xue G; Zhou D; Pan Z
Eur J Med Chem; 2023 Aug; 256():115460. PubMed ID: 37163946
[TBL] [Abstract][Full Text] [Related]
13. Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells.
Samuelson EM; Laird RM; Maue AC; Rochford R; Hayes SM
Immunol Cell Biol; 2012 Jul; 90(6):620-9. PubMed ID: 21894171
[TBL] [Abstract][Full Text] [Related]
14. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
Akerblad P; Sigvardsson M
J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
[TBL] [Abstract][Full Text] [Related]
15. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
Tretter T; Ross AE; Dordai DI; Desiderio S
J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
[TBL] [Abstract][Full Text] [Related]
16. Kinase-independent potentiation of B cell antigen receptor-mediated signal transduction by the protein tyrosine kinase Src.
Lin J; Tao J; Dyer RB; Herzog NK; Justement LB
J Immunol; 1997 Nov; 159(10):4823-33. PubMed ID: 9366407
[TBL] [Abstract][Full Text] [Related]
17. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
Winiarska M; Bojarczuk K; Pyrzynska B; Bil J; Siernicka M; Dwojak M; Bobrowicz M; Miazek N; Zapala P; Zagozdzon A; Krol M; Syta A; Podszywalow-Bartnicka P; Pilch Z; Dabrowska-Iwanicka A; Juszczynski P; Efremov DG; Slabicki M; Zenz T; Le Roy A; Olive D; Rygiel TP; Leusen JH; Golab J
MAbs; 2014; 6(5):1300-13. PubMed ID: 25517315
[TBL] [Abstract][Full Text] [Related]
19. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract][Full Text] [Related]
20. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.
Wu YY; Georg I; Díaz-Barreiro A; Varela N; Lauwerys B; Kumar R; Bagavant H; Castillo-Martín M; El Salem F; Marañón C; Alarcón-Riquelme ME
J Immunol; 2015 Jun; 194(12):5692-702. PubMed ID: 25972485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
